Largest, most rigorous study to date confirms CBD oil helps some kids with epilepsy

[Purple Power]

Largest, most rigorous study to date confirms CBD oil helps some kids with epilepsy
"This is the first solid, rigorously obtained scientific data" that a marijuana compound is safe and effective for this problem, said one study leader

May 25, 2017





<p class="">By <span><a class="" href="http://www.thecannabist.co/author/ap/">The Associated Press</a></span>

<p class="">

A medicine made from marijuana, without the stuff that gives a high, cut seizures in kids with a severe form of epilepsy in a study that strengthens the case for more research into pots possible health benefits.



This is the first solid, rigorously obtained scientific data that a marijuana compound is safe and effective for this problem, said one study leader, Dr. Orrin Devinsky of NYU Langone Medical Center.



He said research into promising medical uses has been hampered by requiring scientists to get special licenses, plus legal constraints and false notions of how risky marijuana is.



Opiates kill over 30,000 Americans a year, alcohol kills over 80,000 a year. And marijuana, as best we know, probably kills less than 50 people a year, Devinsky said......





<a data-ipb="nomediaparse" href="http://www.thecannabist.co/2017/05/25/cannabidiol-cbd-oil-epilepsy-medical-study/80258/">http://www.thecannabist.co/2017/05/25/cannabidiol-cbd-oil-epilepsy-medical-study/80258/</a>

[Purple Power]

Benefits of medical marijuana for treatment of epilepsy examined




Date: May 24, 2017



Source: Elsevier



Summary: Although cannabis had been used for many centuries for treatment of seizure disorders, medical use became prohibited in the 20th century. However, with the loosening of laws regarding medical marijuana, research and clinical use of marijuana-derived substances are increasing. This has prompted the publishing of an in-depth assessment of the potential of cannabinoids for the effective treatment of epilepsy. Cannabinoids are components of the cannabis plant....



<a data-ipb="nomediaparse" href="https://www.sciencedaily.com/releases/2017/05/170524131139.htm">https://www.sciencedaily.com/releases/2017/05/170524131139.htm</a>

[Purple Power]

GW Pharma details an impressive PhIII case for a cannabis-based drug for severe epilepsy as it preps an NDAby <span><span><a data-ipb="nomediaparse" href="https://endpts.com/about/#John%20Carroll">John Carroll</a><a data-ipb="nomediaparse" href="mailto:john@endpointsnews.com?subject=Regarding%20your%20article&body=Hello%2C%20John%20Carroll%0AI%27m%20writing%20regarding%20article%20GW%20Pharma%20details%20an%20impressive%20PhIII%20case%20for%20a%20cannabis-based%20drug%20for%20severe%20epilepsy%20as%20it%20preps%20an%20NDA%20which%20is%20located%20at%20https%3A%2F%2Fendpts.com%2Fgw-pharma-details-an-impressive-phiii-case-for-a-cannabis-based-drug-for-severe-epilepsy-as-it-preps-an-nda%0A" title="Contact author"></a></span></span> on
May 25, 2017



GW Pharmaceuticals lined up a straight shot at a key approval for Epidiolex today, publishing its impressive Phase III data for a severe form of childhood epilepsy which inspired a blockbuster forecast for the cannabis-based therapy.



GW announced last spring that Epidiolex a liquid therapy using purified cannabadiol triggered a mean reduction in convulsive seizures of 39% among treatment-resistant patients with Dravet syndrome, compared to only 13% among the placebo group. A report published in The New England Journal of Medicine adds today that 43% of the drug group had a mean drop of 50% or more compared to 27% in the placebo group. And 5% stopped having seizures, with none in the placebo arm doing as well.......





<a data-ipb="nomediaparse" href="https://endpts.com/gw-pharma-details-an-impressive-phiii-case-for-a-cannabis-based-drug-for-severe-epilepsy-as-it-preps-an-nda/">https://endpts.com/gw-pharma-details-an-impressive-phiii-case-for-a-cannabis-based-drug-for-severe-epilepsy-as-it-preps-an-nda/</a>